Akebia Therapeutics is Biotechnology in United States that focus on Akebia Therapeutics Inc business. Founded in 2007. They cover business area such as Akebia Therapeutics Inc, commercialization, novel therapeutic, patient, kidney disease, hypoxia-inducible factor, (HIF, biology, its lead product candidate, Vadadustat, an oral therapy, anemia, United States.
2007
( 17 years old in 2024 )
Akebia Therapeutics Inc
-
245 First Street
Suite 1400
Cambridge, MA 02142
United States
Private
Akebia Therapeutics Inccommercializationnovel therapeuticpatientkidney diseasehypoxia-inducible factor(HIFbiologyits lead product candidateVadadustatan oral therapyanemiaUnited States
* We use standard office opening hours in near Akebia Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Akebia Therapeutics is Biotechnology business from United States that founded in 2007 (17 years old in 2024), Akebia Therapeutics business is focusing on Akebia Therapeutics Inc.
Akebia Therapeutics headquarter office and corporate office address is located in 245 First Street Suite 1400 Cambridge, MA 02142 United States.
Akebia Therapeutics was founded in United States.
In 2024, Akebia Therapeutics is currently focus on Akebia Therapeutics Inc sector.
Above is snippet of Google Trends for "Akebia Therapeutics Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Akebia Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
